[ Sat, Feb 22nd ]: TechCrunch
[ Sat, Feb 22nd ]: Forbes
[ Sat, Feb 22nd ]: eNCA
[ Sat, Feb 22nd ]: AOL
[ Sat, Feb 22nd ]: GOBankingRates
[ Sat, Feb 22nd ]: AOL
[ Sat, Feb 22nd ]: Week99er
[ Sat, Feb 22nd ]: Kiplinger
[ Sat, Feb 22nd ]: MSN
[ Sat, Feb 22nd ]: MSN
[ Sat, Feb 22nd ]: Tuko
[ Sat, Feb 22nd ]: CNN
[ Sat, Feb 22nd ]: MSN
[ Sat, Feb 22nd ]: MSN
[ Sat, Feb 22nd ]: Kiplinger
[ Fri, Feb 21st ]: Inc
[ Fri, Feb 21st ]: jacobin
[ Fri, Feb 21st ]: Marketplace
[ Fri, Feb 21st ]: Calendar
[ Fri, Feb 21st ]: Politico
[ Fri, Feb 21st ]: Salon
[ Fri, Feb 21st ]: coloradopolitics
[ Fri, Feb 21st ]: CNN
[ Fri, Feb 21st ]: manilatimes
[ Fri, Feb 21st ]: Fortune
[ Fri, Feb 21st ]: Investopedia
[ Fri, Feb 21st ]: Reuters
[ Fri, Feb 21st ]: AOL
[ Fri, Feb 21st ]: Kiplinger
[ Fri, Feb 21st ]: Kiplinger
[ Fri, Feb 21st ]: Reuters
[ Fri, Feb 21st ]: Forbes
[ Fri, Feb 21st ]: Reuters
[ Fri, Feb 21st ]: Forbes
[ Fri, Feb 21st ]: Forbes
[ Fri, Feb 21st ]: AOL
[ Fri, Feb 21st ]: Bloomberg
[ Fri, Feb 21st ]: MSN
[ Fri, Feb 21st ]: Fortune
[ Fri, Feb 21st ]: MSN
[ Fri, Feb 21st ]: Zawya
[ Fri, Feb 21st ]: MSN
[ Fri, Feb 21st ]: MSN
[ Fri, Feb 21st ]: cnbctv18
[ Fri, Feb 21st ]: Reuters
[ Fri, Feb 21st ]: Bloomberg
[ Fri, Feb 21st ]: Forbes
AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M Deal
🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
By selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially resuming development of roxadustat in another indication.
Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/general/astrazeneca-secures-china-rights-to-anemia-drug-buying-fibrogen-unit-in-160m-deal/ar-AA1zxf6q ]